Keith A. Goldan

SNDX

Keith A. Goldan serves as officer: Chief Financial Officer at Syndax Pharmaceuticals, Inc. (SNDX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$25.0K

Total Sells

7 trades

$292.2K

Net Position

Net Seller

$267.1K

Companies Traded

SNDX

Active Period

Jun 2023 – Jun 2026

8 total trades

Most Recent

Sell SNDX

Jun 2, 2026 · $22.4K

Keith A. Goldan's Insider Trading at Syndax Pharmaceuticals, Inc. (SNDX)

Buys

1 · $25.0K

Sells

7 · $292.2K

Total Shares Bought

1,250

Total Shares Sold

15,729

SNDX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 2, 2026	Sell	1,177	$18.99	$22.4K	139,252
Feb 10, 2026	Sell	3,410	$21.03	$71.7K	140,429
Feb 9, 2026	Sell	3,410	$21.03	$71.7K	0
Feb 4, 2026	Sell	2,082	$20.62	$42.9K	0
Jul 16, 2025	Sell	1,296	$9.29	$12.0K	0
Feb 12, 2025	Sell	3,777	$15.50	$58.6K	90,746
Jun 17, 2024	Buy	1,250	$20.03	$25.0K	52,623
Jun 14, 2023	Sell	577	$22.31	$12.9K	2,628

Related Insiders

Nicholas A.J. Botwood

officer: Head of R&D, CMO

SNDXSell · Jun 12, 2026

Michael A Metzger

director, officer: Chief Executive Officer

SNDXSell · Jun 2, 2026

Dennis Podlesak

Director

SNDXSell · Aug 14, 2025

Explore More Insider Trading Data

SNDX Insider Trading Activity

View all insider trades at Syndax Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity